Cannabis and autism, explained
Over the past decade, autistic people and their families have increasingly experimented with medical marijuana and products derived from it.
Over the past decade, autistic people and their families have increasingly experimented with medical marijuana and products derived from it.
Michelle Singh Gori still remembers watching Ryan convulse on the floor, eyes rolled back into his head, foaming at the mouth. She still remembers the severe seizures that would grip her nine-year-old autistic son.
Anecdotal evidence of successful cannabis treatment in autism spectrum disorder (ASD) are accumulating but clinical studies are lacking. Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients. This preliminary study supports feasibility of CBD-based cannabis trials in children with ASD.
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication, restricted and repetitive patterns of behavior, interests, or activities and often intellectual disabilities. There is increasing interest in cannabinoids, especially cannabidiol (CBD), as monotherapy or add-on treatment for the core symptoms and co-morbidities of ASD.